Competition record
Welsh Carson
Deep profile · 1 linked library matter
Welsh Carson is the private equity firm named with US Anesthesia Partners. A 30 September 2026 order let the principal hospital claims proceed and dismissed a count that treated the firm's entities as separate conspirators.
Overview
Welsh Carson invests in and directs companies rather than employing the anesthesiologists itself. In this case it is named alongside US Anesthesia Partners, the platform that bought local anesthesia groups.
On 30 September 2026 the court let the principal hospital claims proceed. Those claims describe a roll-up plus a billing arrangement.
The same order dismissed a count that treated related Welsh Carson entities as if they had conspired with one another. The case is not over.
Competition footprint
The firm's role is ownership and direction of the anesthesia platform, not a hospital of its own.
The court left the main hospital-monopoly theory in place against that structure.
It refused to treat affiliated entities as separate conspirators, and that count is dismissed.
Consumer & business angle
Hospitals that contract for anesthesia coverage are the customers in the surviving claims.
US Anesthesia Partners is the operating company, and Welsh Carson is the investor still facing the claims the court kept.
What to watch
- How the hospital claims proceed against the firm.
- The dismissed intra-firm conspiracy count, which does not continue.
Markets
private equity · healthcare investments · hospital anesthesia
Also known as: welsh carson anderson and stowe, wcas